Report Content
Chapter 1 Methodology and Scope
1.1 Market scope and definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates and calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of Lyme disease
3.2.1.2 Advancements in diagnostic technologies
3.2.1.3 Rising adoption of at-home test kits
3.2.1.4 Growth in point-of-care testing
3.2.1.5 Integration of artificial intelligence (AI)
3.2.2 Industry pitfalls and challenges
3.2.2.1 High cost of advanced diagnostic tests
3.2.2.2 Lack of standardized testing guidelines
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Reimbursement scenario
3.6 Technology landscape
3.7 Gap analysis
3.8 Porter's analysis
3.9 PESTEL analysis
3.10 Value chain analysis
Chapter 4 Competitive Landscape, 2024
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Diagnostic Technology, 2021 – 2034 ($ Mn)
5.1 Key trends
5.2 Serological test
5.2.1 ELISA
5.2.2 Western blot
5.3 Nucleic acid test
5.4 Urine antigen testing
5.5 Lymphocytic transformation test
5.6 Immunofluorescent staining
Chapter 6 Market Estimates and Forecast, By Sample Type, 2021 – 2034 ($ Mn)
6.1 Key trends
6.2 Blood
6.3 Urine
6.4 CSF
6.5 Other blood samples
Chapter 7 Market Estimates and Forecast, By Patient Type, 2021 – 2034 ($ Mn)
7.1 Key trends
7.2 Adult
7.3 Pediatric
Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)
8.1 Key trends
8.2 Hospitals
8.3 Diagnostic laboratories
8.4 Other end use
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
Chapter 10 Company Profiles
10.1 bioMérieux
10.2 Bio-Rad Laboratories
10.3 Ceres Nanosciences
10.4 DiaSorin
10.5 Galaxy Diagnostics
10.6 Gold Standard Diagnostics
10.7 IGeneX
10.8 Oxford Immunotec
10.9 T2 Biosystems
10.10 Thermo Fisher Scientific
10.11 Trinity Biotech
10.12 ZEUS Scientific
